Skip to main content
Clinical Trials/NCT03651388
NCT03651388
Completed
Not Applicable

Research Into the Molecular Bases of a New Phenotype Combining Premature White Hair, Polycystic Kidney Disease, Aortic Dilation/Dissection and Lymphopenia

Centre Hospitalier Universitaire Dijon1 site in 1 country4 target enrollmentJune 1, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
New Phenotype (Combining Premature White Hair, Polycystic Kidney Disease, Aortic Dilation/Dissection and Lymphopenia)
Sponsor
Centre Hospitalier Universitaire Dijon
Enrollment
4
Locations
1
Primary Endpoint
Bcl-2-regulating miRNA sequencing
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This study involves a single family, including 1 patient, father, mother and sister. The patient presented with a new phenotype associating premature white hair, renal polycystosis, aortic dilation/dissection and lymphopenia. Samples were taken in order to identify the origin of the symptomatology highlighted in the index case.

In addition, it was observed that mice invalidated for bcl-2, normal at birth and indistinguishable from control mice, showed, after one week, a phenotype similar to that observed in this patient.

The overlap between the patient's main clinical signs (lymphopenia, white hair and polycystic renal disease) and the manifestations presented by the invalidated murine model for BCL2 suggests that its phenotype may be secondary to a Bcl-2 expression defect.

Registry
clinicaltrials.gov
Start Date
June 1, 2010
End Date
December 2012
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Bcl-2-regulating miRNA sequencing

Time Frame: Through study completion, an average of 2 years.

Study of the methylation of the BCL2 promoter

Time Frame: Through study completion, an average of 2 years.

Whole genome sequencing of BCL2

Time Frame: Through study completion, an average of 2 years.

Study Sites (1)

Loading locations...

Similar Trials